AcquirerTargetPrice
Octopharma AGLicense to Glycotope’s recombinant technology$90.9 million
Nassua Reinsurance GroupUAM's Traditional Insurance business$63 million
AmerisourceBergen Corp.PharMEDium Healthcare Holdings$2.58 billion
Partners PharmacyTech Pharmacy Services, Inc. N/A